News
INmune Bio to receive US patent for next-generation mesenchymal stromal cell product, CORDStrom: Boca Raton, Florida Saturday, April 19, 2025, 17:00 Hrs [IST] INmune Bio Inc., a c ...
"Deadline: White House" legal analyst Jordan Rubin answers your questions about the Supreme Court, Trump administration ...
Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...
Our immune systems weaken as we get older, making fewer cells that fight infection and help us recover from illness and injury. Scientists aren't completely sure why. They may have a better idea now, ...
Related: This Is the #1 Healthiest Food for Your Immune System, According to an Infectious Disease Doctor. How Many ...
The immune system is comprised of various cells that work in concert to fight off disease. The two immune responses, innate and adaptive, are orchestrated | Immunology ...
To treat glioblastoma, Purdue researchers are developing antibody-based immunotherapies to improve the recruitment and ...
Boca Raton, Florida, US, April 16, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB), a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune ...
Learn how breathing strategies and cold immersion techniques developed by Wim Hof directly impact the autonomic and ...
“Vaccines will aid in the prevention of disease, but it doesn’t mean the sheep are not going to get sick,” she said. “The ...
Pheast Therapeutics has treated the first patient in a phase 1 trial of PHST001, a novel macrophage checkpoint inhibitor for advanced solid tumors.
Deciphering the gut biome's, including helminths', influence on human trained immunity will unlock novel immunotherapies harnessing the immune reprogramming potential of their secreted factors and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results